Gupta Ashwaria
Sr. CRA Group Head, Novartis Health Care Private Limited, Sandoz House, Worli, Mumbai, India.
Perspect Clin Res. 2013 Apr;4(2):144-7. doi: 10.4103/2229-3485.111800.
Fraud and misconduct in clinical research is widespread. Good clinical practice is a guideline adopted internationally as standard operating procedure for conduct of clinical research. Despite these guidelines being available, unavailability of internationally harmonized framework for managing research fraud and misconduct makes clinical research a highly vulnerable area to commit fraud. Fraud could be of various types and due to various reasons. Whatever the circumstances be, any fraud should be dealt with strictly and regulations should be in place to prevent its occurrence.
临床研究中的欺诈和不当行为普遍存在。良好临床实践是国际上采用的作为临床研究操作标准程序的指南。尽管有这些指南，但由于缺乏管理研究欺诈和不当行为的国际统一框架，临床研究成为极易发生欺诈的领域。欺诈可能有多种类型且原因各异。无论情况如何，任何欺诈行为都应受到严厉处理，并且应制定相关规定以防止其发生。
